Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched, including brain excitatory neurons; strongest in retinal ganglion cells | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 7 Parkinson's papers of 117 | 0.73 |
| pathways Reactome | 1 pathway; mostly dopamine synapse | 1.00 |
No case: the score is under the bar. Receipt 5343
Sealed predictions
- SLC17A6 in dopamine neurons, braak+0.26 (p 0.502) → +0.36 (p 0.348)receipt 5350
Swarm cases
receipt 5350: SLC17A6 in dopamine neurons, braak
- power
- full sample +0.32 (p 0.191, n 18), 95% CI -0.17 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.38 (p 0.120, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range +0.24 to +0.49, sign flips 0; without severely affected donors +0.32 (p 0.191, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC17A6 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts